EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling

Pulmonary arterial hypertension (PAH) is commonly associated with chronic hypoxemia in disorders such as chronic obstructive pulmonary disease (COPD). Prostacyclin analogs are widely used in the management of PAH patients; however, clinical efficacy and long-term tolerability of some prostacyclin an...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Clin Invest
المؤلفون الرئيسيون: Lu, Ankang, Zuo, Caojian, He, Yuhu, Chen, Guilin, Piao, Lingjuan, Zhang, Jian, Xiao, Bing, Shen, Yujun, Tang, Juan, Kong, Deping, Alberti, Sara, Chen, Di, Zuo, Shenkai, Zhang, Qianqian, Yan, Shuai, Fei, Xiaochun, Yuan, Fei, Zhou, Bin, Duan, Shengzhong, Yu, Yu, Lazarus, Michael, Su, Yunchao, Breyer, Richard M., Funk, Colin D., Yu, Ying
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Clinical Investigation 2015
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362262/
https://ncbi.nlm.nih.gov/pubmed/25664856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI77656
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة